[Circulating immune complexes and insulin antibodies in obesity in children]

Area of Science:

• Pediatric Endocrinology
• Immunology
• Metabolic Disorders

Background:

• Obesity in children is a growing concern with complex underlying mechanisms.
• Insulin resistance is a common complication of pediatric obesity.
• The role of immune system components like circulating immune complexes (CIC) and insulin antibodies in obesity is not fully understood.

Purpose of the Study:

• To investigate the levels of CIC and insulin antibodies in obese children compared to normal-weight controls.
• To explore the potential association between CIC, insulin antibodies, and insulin resistance in pediatric obesity.
• To assess the possible link between these immune markers and the development of autoimmune processes in obese children.

Main Methods:

• Clinical and laboratory assessments were performed on 110 children aged 7-14 years.
• The study included 90 obese children and 20 normal-weight children.
• Measurements included circulating immune complexes (CIC) and insulin antibodies.

Main Results:

• Obese children exhibited significantly higher levels of CIC compared to normal-weight children.
• Elevated levels of insulin antibodies were also observed in the obese pediatric group.
• The presence of pathogenic CIC in obese children suggests a potential for autoimmune activity.

Conclusions:

• Obese children demonstrate increased CIC and insulin antibodies, indicating immune system dysregulation.
• The findings suggest that autoimmune processes may contribute to the pathophysiology of pediatric obesity.
• Insulin resistance in obese children is likely associated with the presence of insulin antibodies.